BioSpace News Archive

Policy

False Alarm? Vertex Stock Drops on Database Report of 30 Deaths Associated with Symdeko for Cystic Fibrosis

The report, which is exaggerated or misinterpreted, appears to have been erroneous and triggered a short stock drop before the company and various analysts responded, calming investors.

August 29, 2019

·

3 min read

·

Mark Terry

Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.

GoodRx released an analysis that showed only 8% of fills at local pharmacies are for the Lispro Injection. The majority of insulin scripts are still being ordered for Humalog, the analysis showed.

August 29, 2019

·

4 min read

·

Alex Keown

Business

BioSpace Movers & Shakers, Aug. 30

Biopharma companies strengthen their leadership and boards with these appointments.

August 29, 2019

·

5 min read

·

Alex Keown

Policy

FDA Action Alert: Celgene, Xeris and Ardelyx

In the first two weeks of September there were three scheduled PDUFA dates. One of those dates, for Celgene’s myelofibrosis drug, was approved early. Here’s a look.

August 29, 2019

·

3 min read

·

Mark Terry

Policy

Promore Pharma is Granted a Patent for LL-37 in Japan

Promore Pharma AB today announced that the company was granted a patent in Japan for the usage of LL-37 for treating chronic wounds.

August 29, 2019

·

3 min read

Pharm Country

Enterin’s RASMET Study Published

Enterin Inc. announces the publication of its Phase 2a RASMET study.

August 29, 2019

·

3 min read

Bio NC

Novo Nordisk Foundation Awards $27 Million to Improve Bioindustry and Green Activities

The funds will be used to support an international research and education collaboration to create new bioindustrial processes using biotechnology and educational programs for students and staff in the industry. They are designed to optimize bioindustrial production and advance a green transformation.

August 29, 2019

·

3 min read

·

Mark Terry

Business

Verdemed, which is building the medical cannabis brand of choice for Latin America, announces the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer

VERDEMED HOLDINGS INC. is pleased to announce the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer.

August 29, 2019

·

5 min read

Policy

ADCendo Accepted into the Creation House Program of BioInnovation Institute (BII), Securing a Convertible Loan of 10 Million DKK

ADCendo ApS, a spin-out from the University of Copenhagen and Rigshospitalet, announces having been accepted into the BioInnovation Institute Creation House program.

August 29, 2019

·

7 min read

Deals

Epizyme to Participate in Upcoming September Conferences - Aug. 29, 2019

Epizyme, Inc. announced that Robert Bazemore, president and chief executive officer, will participate in the following September investor conferences

August 29, 2019

·

1 min read